x ZP k qYioG UARhOqfe W

UNMC Faculty Member Heads Accreditation Program For Continent’s Cellular Transplantation Facilities

A two-year effort to establish uniform standards for bone

marrow, and other cellular transplantation treatments in North

America, has resulted in the implementation of an accreditation

program headed by a faculty member at the University of Nebraska

Medical Center.

The accreditation program also will be headquartered at UNMC.

Phyllis Warkentin, M.D., professor of pathology and

microbiology, and pediatrics, and medical director of UNMC’s

unrelated-donor marrow transplant program, has served as chairman

of the accreditation program of the Foundation for the

Accreditation of Hematopoietic Cell Therapy (FAHCT) since it was

formed in 1995. During the past two years she has devoted time to

establishing the foundation’s office and development of the

accreditation process that the foundation is intended to operate.

The initial tasks are almost complete, Dr. Warkentin said, and

the foundation recently hired an office administrator. To date,

101 facilities across the continent have agreed to participate in

the voluntary accreditation process. Seven of these facilities

already have been inspected. In addition, the foundation has

completed the first edition of FACHT Standards and a companion

accreditation manual to assist transplant programs, cell

collection facilities and cell-processing laboratories in their

efforts to comply with FAHCT standards. The foundation also held

a training workshop last year in Omaha for 80 accreditation

inspectors.

Dr. Warkentin said every facility in North America that

performs at least 10 transplants per year is eligible to

participate in the accreditation process. That would mean between

about 200 to 300 facilities in North America would be able to

participate in the program, she said.

FAHCT was formed after two similar organizations combined

their standard-setting efforts.

The two groups are the International Society for Hematotherapy

and Graft Engineering (ISHAGE), which is a laboratory-oriented

organization, and the American Society of Blood and

Marrow Transplantation (ASBMT), which is a clinical transplant

research organization.

"The clinical group wrote a set of standards, as did the

laboratory group," Dr. Warkentin said. "Then, it was

decided that the process would be better if merged."

The accreditation process is voluntary, she said, but a set of

standards is vital in assuring continued high-quality research

and patient care in the field. In addition, the Food and Drug

Administration has announced its intent to regulate the field of

hematopoietic cell transplantation — but has suggested that it

may be less likely to inspect facilities accredited by FAHCT, if

FAHCT is able to establish and maintain a credible accreditation

program.

"One of the overall goals of this program is to provide

evidence that we can regulate ourselves to achieve measurable

good," Dr. Warkentin said. "Still, the real purpose is

to provide the highest level of laboratory and clinical care for

patients receiving this type of treatment."

Dr. Warkentin was a natural choice to lead the accreditation

effort. She is a member of both ISHAGE and ASBMT. She has worked

in both clinical and laboratory cellular transplantation since

the early 1980s, and has been heavily involved in related

research during the same period. She also

served as chairman of the Standards Committee of the National

Marrow Donor Program, and as a member of the Standards Committee

of the American Association of Blood Banks.

Dr. Warkentin joined the UNMC faculty in 1988. In 1989, UNMC

was accepted as a transplantation center for unrelated-donor bone

marrow transplants. Dr. Warkentin has coordinated the program

since its start.

UNMC is the only public academic health science center in the

state. Through its commitment to research, education and patient

care, UNMC has established itself as one of the

country’s leading centers for cancer research and treatment

and solid organ transplantation. Millions of dollars in research

grants and contracts are awarded to UNMC scientists annually. In

addition, UNMC’s educational programs are responsible for

training more health professionals practicing in Nebraska than

any other institution.